Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report

Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.

Detalles Bibliográficos
Autores principales: Abdelmahmuod, Elabbass A., Ali, Elrazi, Ahmed, Mohanad A., Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981772/
https://www.ncbi.nlm.nih.gov/pubmed/33768857
http://dx.doi.org/10.1002/ccr3.3783
_version_ 1783667583946326016
author Abdelmahmuod, Elabbass A.
Ali, Elrazi
Ahmed, Mohanad A.
Yassin, Mohamed A.
author_facet Abdelmahmuod, Elabbass A.
Ali, Elrazi
Ahmed, Mohanad A.
Yassin, Mohamed A.
author_sort Abdelmahmuod, Elabbass A.
collection PubMed
description Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.
format Online
Article
Text
id pubmed-7981772
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79817722021-03-24 Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report Abdelmahmuod, Elabbass A. Ali, Elrazi Ahmed, Mohanad A. Yassin, Mohamed A. Clin Case Rep Case Reports Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders. John Wiley and Sons Inc. 2021-01-21 /pmc/articles/PMC7981772/ /pubmed/33768857 http://dx.doi.org/10.1002/ccr3.3783 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Abdelmahmuod, Elabbass A.
Ali, Elrazi
Ahmed, Mohanad A.
Yassin, Mohamed A.
Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_full Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_fullStr Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_full_unstemmed Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_short Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_sort eltrombopag and its beneficial role in management of ulcerative colitis associated with itp as an upfront therapy case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981772/
https://www.ncbi.nlm.nih.gov/pubmed/33768857
http://dx.doi.org/10.1002/ccr3.3783
work_keys_str_mv AT abdelmahmuodelabbassa eltrombopaganditsbeneficialroleinmanagementofulcerativecolitisassociatedwithitpasanupfronttherapycasereport
AT alielrazi eltrombopaganditsbeneficialroleinmanagementofulcerativecolitisassociatedwithitpasanupfronttherapycasereport
AT ahmedmohanada eltrombopaganditsbeneficialroleinmanagementofulcerativecolitisassociatedwithitpasanupfronttherapycasereport
AT yassinmohameda eltrombopaganditsbeneficialroleinmanagementofulcerativecolitisassociatedwithitpasanupfronttherapycasereport

Ejemplares similares